Barclays (BCS) to Offer Existing Investors Preference Shares Related to Capital Infusion -WSJ

According to a Wall Street Journal article published this morning, Barclays (NYSE: BCS) has given into investor complaints related to its recently announced capital-injection plan.

Ahead of the next Monday's shareholder vote, Barclays said it will allow existing shareholders some of the same terms that Middle Eastern investors are receiving for their equity investments. Specifically, existing Barclays shareholders will receive shares similar to preference stock.

The WSJ article notes that Barclays original agreement with investors from Qatar includes selling a 32% stake in the company, in exchange for a lofty 14% return on preferred shares through 2019.

Barclays PLC engages in the provision of financial services worldwide.

You May Also Be Interested In

• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• Baiya International Group (BIYA) files $200M mixed shelf
• Buyout firm Vista explores $3B sale of private markets data provider Allvue - Reuters